MX2016010680A - Perfeccionamiento de expresión de proteína recombinante con el uso de un sistema de retención de célula basado en membrana. - Google Patents

Perfeccionamiento de expresión de proteína recombinante con el uso de un sistema de retención de célula basado en membrana.

Info

Publication number
MX2016010680A
MX2016010680A MX2016010680A MX2016010680A MX2016010680A MX 2016010680 A MX2016010680 A MX 2016010680A MX 2016010680 A MX2016010680 A MX 2016010680A MX 2016010680 A MX2016010680 A MX 2016010680A MX 2016010680 A MX2016010680 A MX 2016010680A
Authority
MX
Mexico
Prior art keywords
retention system
cell
membrane
enhancement
protein expression
Prior art date
Application number
MX2016010680A
Other languages
English (en)
Inventor
Seyit Ozturk Sadettin
Original Assignee
Advantech Bioscience Farmacêutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advantech Bioscience Farmacêutica Ltda filed Critical Advantech Bioscience Farmacêutica Ltda
Publication of MX2016010680A publication Critical patent/MX2016010680A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/28Constructional details, e.g. recesses, hinges disposable or single use
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/02Membranes; Filters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10Perfusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Clinical Laboratory Science (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se trata del uso innovador de un sistema de retención de célula basado en membrana externa conjuntamente con cultivo celular de perfusión para expresión celular mejorada de proteínas recombinantes, particularmente proteínas de coagulación, tales como rFVIII, rFVIII con Dominio B Eliminado, rFIX o rFVII/rFVIIa. El uso de tal sistema en alta densidad de celula resulta en un cultivo celular más homogéneo debido a las fuerzas mecánicas inducidas durante la operación del sistema de retención, tales como la circulación celular inducida por bombeo a través de las fibras, además que la retención de algunos componentes celulares y de medio permite un ambiente ideal para las células. El uso del método proporcionado resulta en mejoras en productividad celular y en productividad volumétrica. El sistema de retención de célula basado en membrana es descartable y cuando es conectado a un biorreactor descartable, el mismo permite que todo el sistema de perfusión sea descartable cuando el medio y la recolección son desechados en sacos descartables. El sistema biorreactor de perfusión descartable puede ser operado como un sistema cerrado y no requiere limpieza, vaporización o el uso de una instalación con tubería rígida.
MX2016010680A 2014-02-17 2015-02-12 Perfeccionamiento de expresión de proteína recombinante con el uso de un sistema de retención de célula basado en membrana. MX2016010680A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461940493P 2014-02-17 2014-02-17
PCT/BR2015/000019 WO2015120527A2 (en) 2014-02-17 2015-02-12 Enhancement of recombinant protein expression using a membrane-based cell retention system

Publications (1)

Publication Number Publication Date
MX2016010680A true MX2016010680A (es) 2017-04-27

Family

ID=53800716

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016010680A MX2016010680A (es) 2014-02-17 2015-02-12 Perfeccionamiento de expresión de proteína recombinante con el uso de un sistema de retención de célula basado en membrana.

Country Status (11)

Country Link
US (1) US20170009269A1 (es)
EP (1) EP3107934A4 (es)
JP (1) JP2017506077A (es)
KR (1) KR20160138403A (es)
CN (1) CN106414490A (es)
AU (1) AU2015218193A1 (es)
BR (1) BR112016018797A8 (es)
CA (1) CA2939872A1 (es)
CL (1) CL2016002068A1 (es)
MX (1) MX2016010680A (es)
WO (1) WO2015120527A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015149143A2 (en) 2014-04-01 2015-10-08 Advantech Bioscience Farmacêutica Ltda. Stable factor viii formulations with low sugar-glycine
AU2015240354A1 (en) 2014-04-01 2016-11-17 Advantech Bioscience Farmaceutica Ltda. Stabilization of Factor VIII without calcium as an excipient
CN111344558A (zh) * 2017-10-06 2020-06-26 龙沙有限公司 使用拉曼光谱法自动控制细胞培养

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200560B1 (en) * 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US20040229335A1 (en) * 2003-05-15 2004-11-18 Introgen Therapeutics, Inc. Methods and compositions for the production of adenoviral vectors
AU2005229359C1 (en) * 2004-03-05 2011-07-28 Patheon Holdings I B.V. Process for cell culturing by continuous perfusion and alternating tangential flow
WO2009018307A2 (en) * 2007-07-31 2009-02-05 Wyeth Analysis of polypeptide production
RS56484B1 (sr) * 2009-11-17 2018-01-31 Squibb & Sons Llc Metode za poboljšanu proizvodnju proteina
US8668886B2 (en) * 2011-04-24 2014-03-11 Therapeutic Proteins International, LLC Separative bioreactor
AU2015234611A1 (en) * 2014-03-23 2016-11-10 Advantech Bioscience Farmaceutica Ltda. Enhancement of recombinant protein expression with copper

Also Published As

Publication number Publication date
CA2939872A1 (en) 2015-08-20
KR20160138403A (ko) 2016-12-05
CL2016002068A1 (es) 2017-08-04
WO2015120527A2 (en) 2015-08-20
EP3107934A4 (en) 2017-10-18
WO2015120527A3 (en) 2015-12-10
CN106414490A (zh) 2017-02-15
BR112016018797A2 (pt) 2017-08-08
US20170009269A1 (en) 2017-01-12
AU2015218193A1 (en) 2016-10-06
EP3107934A2 (en) 2016-12-28
JP2017506077A (ja) 2017-03-02
BR112016018797A8 (pt) 2020-06-23

Similar Documents

Publication Publication Date Title
EA201691669A1 (ru) Связывающие сывороточный альбумин домены фибронектина iii типа
CY1121217T1 (el) Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων
EA202190827A1 (ru) Вирусные векторы, кодирующие рекомбинантные варианты fviii с повышенной экспрессией для генной терапии гемофилии a
SA520412637B1 (ar) B7 الفيروس الغدي الحال للورم المشفِّر لبروتين
CR20170139A (es) Proteínas de fusión, bacterias recombinantes y métodos de uso de las bacterias recombinantes
EA201891142A1 (ru) Контроль клеточных окислительно-восстановительных уровней
EA201491388A1 (ru) Рекомбинантные белки фактора viii
TR201909037T4 (tr) Yeni protein deamidaz.
EA201692025A1 (ru) Доставка белков, осуществляемая на основе бактерий
ES2721309T3 (es) Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa
ES2722773T3 (es) Polipéptidos de fHbp meningocócicos modificados
ES2694667T3 (es) Método para producir oxalato oxidasas que tienen actividad óptica cerca de pH fisiológico y uso de tales oxalato oxidasas recombinantes en el tratamiento de enfermedades relacionadas con oxalato
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
CL2016001900A1 (es) Sobreexpresión de los reguladores de caminos de n-glicosilación para regular la glicosilación de proteinas recombinante
EA202092049A1 (ru) Вирусные векторы, кодирующие рекомбинантные варианты fviii с повышенной экспрессией для генной терапии гемофилии a
MX2016010680A (es) Perfeccionamiento de expresión de proteína recombinante con el uso de un sistema de retención de célula basado en membrana.
PH12016500708A1 (en) Recombinant glycoproteins and uses thereof
MX2020003626A (es) Expresión recombinante de la proteína orf2 de pcv2b en células de insecto.
MX2016007224A (es) Vacuna contra el circovirus porcino tipo 2.
MX2016012428A (es) Aumento de la expresion de proteina recombinante con cobre.
RU2013146452A (ru) Инъекционный или инфузионный раствор триазавирина для лечения вирусных инфекций
SG10201803999UA (en) Recombinant factor viii formulations
UA118653C2 (uk) Суперагоністи глікопротеїнового гормону тривалої дії
PH12015502037B1 (en) Activating adiponectin by casein hydrolysate
EA201591832A1 (ru) Коэкспрессия фактора viii и фактора фон виллебранда